Find Consultations

Title or Description

Status

Audience

Interest

Department

2 results

Sort by:

Emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors (all ages)

NHS England has launched a 30 day consultation on Emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors (all ages). Haemophilia A is a rare condition that affects the blood's ability to clot. It is usually inherited and usually occurs in... More

Opened 1 week ago
Clinical Reference Group Stakeholder Registration - April 2019

Stakeholder registration is open for all stakeholders, including patients, carers, service users, members of the public, clinical staff, provider organisations working in specialised services and voluntary sector partners. On registration you will be asked to tell us a bit more about who you... More

Opened 3 weeks ago

2 results. Page 1 of 1

Emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors (all ages)